FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2110506521> ?p ?o ?g. }

• W2110506521 endingPage "742" @default.
• W2110506521 startingPage "736" @default.
• W2110506521 abstract "Treatment with ursodeoxycholic acid has been shown to decrease the rate of disease progression in patients with primary biliary cirrhosis, although the effect is modest. Since primary biliary cirrhosis has many features of an autoimmune disorder, immunosuppressives added to ursodeoxycholic acid may be of value in the treatment of primary biliary cirrhosis.A 1-year randomized, double-blind, placebo-controlled trial was carried out in 50 patients with primary biliary cirrhosis, who had already been treated with ursodeoxycholic acid for at least 1 year, but had not achieved complete disease remission. Patients were randomized to additional prednisone (30 mg per day initially, tapered to 10 mg daily after 8 weeks) and azathioprine (50 mg daily) or placebo. A subgroup of patients received cyclical etidronate and calcium. The principal aim of the study was to assess the short-term benefits and risks of the combined bile acid and low-dose immunosuppressive regimen. Primary endpoints were effects on symptoms, liver biochemistry, liver histology, bone mass and the occurrence of adverse events.Pruritus (p=0.02), alkaline phosphatase, aspartate aminotransferase, IgM and procollagen-III-propeptide improved significantly (all p<0.002) in the combined treatment group as compared to the placebo group. Histological scores for disease activity and disease stage decreased significantly within the combination treatment group (p<0.001).In patients with primary biliary cirrhosis receiving ursodeoxycholic acid, there is an additional beneficial effect of 1-year treatment with prednisone and azathioprine on symptoms and biochemical, fibrogenetic and histological parameters. These results strongly encourage the evaluation of this triple treatment regimen in long-term controlled trials of adequate size to document its effect on clinical events." @default.
• W2110506521 created "2016-06-24" @default.
• W2110506521 creator A5015062996 @default.
• W2110506521 creator A5015477415 @default.
• W2110506521 creator A5017441523 @default.
• W2110506521 creator A5017907034 @default.
• W2110506521 creator A5028109035 @default.
• W2110506521 creator A5034065954 @default.
• W2110506521 creator A5053627313 @default.
• W2110506521 creator A5063335507 @default.
• W2110506521 creator A5072567996 @default.
• W2110506521 creator A5073092915 @default.
• W2110506521 creator A5080278217 @default.
• W2110506521 creator A5080738652 @default.
• W2110506521 creator A5083852688 @default.
• W2110506521 creator A5086698790 @default.
• W2110506521 date "1998-11-01" @default.
• W2110506521 modified "2023-09-27" @default.
• W2110506521 title "Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study" @default.
• W2110506521 cites W1538988009 @default.
• W2110506521 cites W1542349269 @default.
• W2110506521 cites W1659316944 @default.
• W2110506521 cites W1744331491 @default.
• W2110506521 cites W1933899624 @default.
• W2110506521 cites W1966918317 @default.
• W2110506521 cites W1968051640 @default.
• W2110506521 cites W1970664739 @default.
• W2110506521 cites W1975722831 @default.
• W2110506521 cites W1981900811 @default.
• W2110506521 cites W1987419992 @default.
• W2110506521 cites W2007835049 @default.
• W2110506521 cites W2012146760 @default.
• W2110506521 cites W2012368291 @default.
• W2110506521 cites W2013190926 @default.
• W2110506521 cites W2023036579 @default.
• W2110506521 cites W2028798921 @default.
• W2110506521 cites W2039586762 @default.
• W2110506521 cites W2051625114 @default.
• W2110506521 cites W2051675398 @default.
• W2110506521 cites W2056617885 @default.
• W2110506521 cites W2060123467 @default.
• W2110506521 cites W2075432722 @default.
• W2110506521 cites W2094683980 @default.
• W2110506521 cites W2094824408 @default.
• W2110506521 cites W2144740719 @default.
• W2110506521 cites W2148772323 @default.
• W2110506521 cites W2149707203 @default.
• W2110506521 cites W2335475908 @default.
• W2110506521 cites W290028587 @default.
• W2110506521 cites W51141202 @default.
• W2110506521 cites W55022097 @default.
• W2110506521 doi "https://doi.org/10.1016/s0168-8278(98)80254-7" @default.
• W2110506521 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9833911" @default.
• W2110506521 hasPublicationYear "1998" @default.
• W2110506521 type Work @default.
• W2110506521 sameAs 2110506521 @default.
• W2110506521 citedByCount "78" @default.
• W2110506521 countsByYear W21105065212012 @default.
• W2110506521 countsByYear W21105065212013 @default.
• W2110506521 countsByYear W21105065212014 @default.
• W2110506521 countsByYear W21105065212015 @default.
• W2110506521 countsByYear W21105065212016 @default.
• W2110506521 countsByYear W21105065212017 @default.
• W2110506521 countsByYear W21105065212018 @default.
• W2110506521 countsByYear W21105065212019 @default.
• W2110506521 countsByYear W21105065212020 @default.
• W2110506521 countsByYear W21105065212021 @default.
• W2110506521 countsByYear W21105065212022 @default.
• W2110506521 crossrefType "journal-article" @default.
• W2110506521 hasAuthorship W2110506521A5015062996 @default.
• W2110506521 hasAuthorship W2110506521A5015477415 @default.
• W2110506521 hasAuthorship W2110506521A5017441523 @default.
• W2110506521 hasAuthorship W2110506521A5017907034 @default.
• W2110506521 hasAuthorship W2110506521A5028109035 @default.
• W2110506521 hasAuthorship W2110506521A5034065954 @default.
• W2110506521 hasAuthorship W2110506521A5053627313 @default.
• W2110506521 hasAuthorship W2110506521A5063335507 @default.
• W2110506521 hasAuthorship W2110506521A5072567996 @default.
• W2110506521 hasAuthorship W2110506521A5073092915 @default.
• W2110506521 hasAuthorship W2110506521A5080278217 @default.
• W2110506521 hasAuthorship W2110506521A5080738652 @default.
• W2110506521 hasAuthorship W2110506521A5083852688 @default.
• W2110506521 hasAuthorship W2110506521A5086698790 @default.
• W2110506521 hasConcept C126322002 @default.
• W2110506521 hasConcept C142724271 @default.
• W2110506521 hasConcept C168563851 @default.
• W2110506521 hasConcept C197934379 @default.
• W2110506521 hasConcept C204787440 @default.
• W2110506521 hasConcept C27081682 @default.
• W2110506521 hasConcept C2776760755 @default.
• W2110506521 hasConcept C2777214474 @default.
• W2110506521 hasConcept C2778720950 @default.
• W2110506521 hasConcept C2779075594 @default.
• W2110506521 hasConcept C2779134260 @default.
• W2110506521 hasConcept C2780366471 @default.
• W2110506521 hasConcept C2780965833 @default.
• W2110506521 hasConcept C2994419564 @default.
• W2110506521 hasConcept C71924100 @default.

• next